Best Investments for
These investors could have purchased those in-the-money calls to create a synthetically long position in the underlying common stock.
Pfizer is looking to cut some 1,800 workers during 2019 amid a leadership shakeup.
The Swiss drugmaker will pay $2.1 billion for Endocyte, justifying the Nasdaq-listed biotech's pivot to prostate treatment last year.
As Canada becomes the second country after Uruguay to allow recreational use of cannabis, advances in pot research could follow.
Abbott Laboratories posted third quarter earnings that were largely in-line with analysts' forecasts, but trimmed the upper end of its full-year profit outlook as international sales were hit by a stronger U.S. dollar.
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Daily S&P Biotech Bull 3X Shares where we have detected an approximate $114.6 million dollar inflow -- that's a 29.5% increase week over week in outstanding units (from 6,111,600 to 7,911,600). START SLIDESHOW:Click here to find out which 9 other ETFs had notable inflows » The chart below shows the one year price performance of LABU, versus its 200 day moving average: Looking at the chart above, LABU's low point in its 52 week range is $61.91 per share, with $116.54 as the 52 week high point — that compares with a last trade of $67.21.
Canadian cannabis company Canopy Growth is high on R&D: The company plans to buy the assets of Ebbu, a Colorado-based medicinal marijuana research company.
In trading on Monday, shares of the Biotech ETF entered into oversold territory, changing hands as low as $124.35 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.
Jim Cramer takes a closer look at ConAgra Foods, Caterpillar, FireEye, Becton Dickinson, Loxo Oncology, Alibaba.
President Donald Trump's $1.5 trillion of tax cuts in December are forcing Treasury Department officials to cover the gap by borrowing money in unprecedented amounts, leading to concerns about the country's creditworthiness.
A report Friday from the Department of Labor show that the U.S. added 134,000 jobs last month, below the 184,000 average projection by analysts in a survey by data provider FactSet. It's a slowdown from the 207,000 jobs created in August, but economists say the culprit is a tighter labor market, not a slowing of businesses' expansion plans.
A report Friday from the Department of Labor showed the U.S. added 134,000 jobs last month. That's a slowdown from the 207,000 jobs created in August.
President Donald Trump won "mainly symbolic" concessions in a new trade agreement with Canada and Mexico, according to Bank of America. Now, economists and trade experts are now turning to the thornier question of whether the president's threatened trade war with China, which has cast a pall over financial markets this year, can come to a similarly quick and easy resolution
Yujing Liu email@example.com
Hong Kong also surpasses the US in IPO fundraising for the third quarter, thanks to China Tower's US$7.5b and Meituan Dianping's US$4.2b listings